Eur Rev Med Pharmacol Sci 2019; 23 (14): 6160-6169

DOI: 10.26355/eurrev_201907_18429

MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9

J.-C. Shang, G.-Z. Yu, Z.-W. Ji, X.-Q. Wang, L. Xia

Department of General, the First Affiliated Hospital of Jiamusi University, Jiamusi, China. 33680406@qq.com


OBJECTIVE: Gastric cancer is one of the most common gastrointestinal malignancy, which is often diagnosed at an advanced stage. MicroRNA-105 (miR-105) was downregulated and acts as a tumor suppressor in various cancers. The purpose of this study was to explore the molecular mechanisms of miR-105 and sex-determining region Y-box 9 (SOX9) in gastric cancer.

PATIENTS AND METHODS: Western blot was performed to display the protein level of E-Cadherin, N-Cadherin, Vimentin and SOX9. Transwell assay was utilized to measure the capacity of migration and invasion. We employed the Luciferase reporter assay to determine miR-105 targeting to SOX9 in gastric cancer.

RESULTS: MiR-105 was downregulated in gastric cancer tissues and cells; it suppressed gastric cancer cell migration, invasion and epithelial-mesenchymal transition (EMT) in gastric cancer. SOX9 was upregulated in gastric cancer cells and had a negative correlation with miR-105. Moreover, the knockdown of SOX9 could inhibit gastric cancer cell migration, invasion and EMT. Furthermore, SOX9 was a target gene of miR-105 and mediated by miR-105. SOX9 could reverse the partial function of miR-105 on cell migration and invasion. In addition, miR-105 downregulation or SOX9 upregulation predicted a poor prognosis.

CONCLUSIONS: We showed that miR-105 was downregulated and inhibited cell migration, invasion and EMT in gastric cancer by binding to SOX9. In addition, we demonstrated that miR-105 downregulation or SOX9 upregulation predicted a poor prognosis. The newly discoverable miR-105/SOX9 axis provides novel insight into gastric cancer treatment.

Free PDF Download

To cite this article

J.-C. Shang, G.-Z. Yu, Z.-W. Ji, X.-Q. Wang, L. Xia
MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 14
Pages: 6160-6169
DOI: 10.26355/eurrev_201907_18429